文献速递呼吸衰竭与机械通气消化、代谢与肾脏急症

qSOFA对社区获得性肺炎的预后评估效能

The prognostic performance of qSOFA for community-acquired pneumonia.
PubMed 文献 · J Intensive Care · 2018-08-08
一句话结论住院CAP患者中,qSOFA预测院内死亡和ICU入住的效能与CURB-65、PSI无显著差异,且仅需少数条目和生命体征,作者认为可能特别适用于急诊科或非呼吸专科医生。

本研究为前瞻性观察性研究的二次分析,纳入2010年10月至2016年6月入住作者所在医院的成人CAP患者1045例,中位年龄77(68-83)岁,男性71.4%。比较qSOFA、CURB-65和PSI预测院内死亡和ICU入住的效能,用C统计量评价。qSOFA预测院内死亡的C统计量为0.69(95%CI 0.63-0.75),与CURB-65(0.75;95%CI 0.69-0.81)和PSI(0.74;95%CI 0.69-0.80)无显著差异;预测ICU入住的C统计量为0.76(95%CI 0.71-0.80),与CURB-65(0.73;95%CI 0.67-0.79)和PSI(0.72;95%CI 0.66-0.78)亦无显著差异。作者认为qSOFA仅需少数条目和生命体征,可能特别适用于急诊科或非呼吸专科医生。

要点

  • 在1045例住院CAP患者中,qSOFA预测院内死亡的C统计量为0.69(95%CI 0.63-0.75),与CURB-65(0.75;95%CI 0.69-0.81)和PSI(0.74;95%CI 0.69-0.80)无显著差异。
  • qSOFA预测ICU入住的C统计量为0.76(95%CI 0.71-0.80),与CURB-65(0.73;95%CI 0.67-0.79)和PSI(0.72;95%CI 0.66-0.78)无显著差异。
  • qSOFA仅需少数条目和生命体征,作者认为可能特别适用于急诊科或非呼吸专科医生。
  • 非存活者和ICU入住患者的qSOFA、CURB-65、PSI评分均显著高于存活者和非ICU入住患者(p < 0.001)。
  • 整个队列的院内死亡率为6.1%,ICU入住率为7.9%。

适用人群与场景

  • 2010年10月至2016年6月入住作者所在医院的成人社区获得性肺炎患者,共1045例,中位年龄77(68-83)岁,男性占71.4%。

诊断标准与关键阈值

  • qSOFA为快速脓毒症相关器官衰竭评估评分。
  • CURB-65包含:意识障碍、血尿素氮 > 19 mg/dL、呼吸频率 ≥ 30/min、收缩压 < 90 mmHg或舒张压 ≤ 60 mmHg、年龄 ≥ 65岁。
  • 肺炎严重指数(PSI)为现有肺炎严重程度评分之一。

研究设计与关键结果

  • 研究设计为前瞻性观察性研究的二次分析,纳入1045例住院成人CAP患者。
  • 整个队列的院内死亡率为6.1%,ICU入住率为7.9%。
  • 非存活者和ICU入住患者的qSOFA、CURB-65、PSI评分均显著高于存活者和非ICU入住患者(p < 0.001)。
  • qSOFA预测院内死亡的C统计量为0.69(95%CI 0.63-0.75),与CURB-65(C统计量0.75;95%CI 0.69-0.81)和PSI(C统计量0.74;95%CI 0.69-0.80)无显著差异。
  • qSOFA预测ICU入住的C统计量为0.76(95%CI 0.71-0.80),与CURB-65(C统计量0.73;95%CI 0.67-0.79)和PSI(C统计量0.72;95%CI 0.66-0.78)无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,qSOFA仅需少数条目和生命体征,可能特别适用于急诊科或非呼吸专科医生。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Quick Sepsis-related Organ Failure Assessment (qSOFA) is a new screening system for sepsis. The prognostic performance of qSOFA for patients with suspected infections outside the intensive care unit (ICU) is similar to that of full SOFA; however, its performance for community-acquired pneumonia (CAP) has not yet been evaluated in detail.The objectives of the present study were to compare the prognostic performance of qSOFA with existing pneumonia severity scores, such as CURB-65 (confusion, blood urea nitrogen > 19 mg/dL, respiratory rate ≥ 30/min, systolic blood pressure < 90 mmHg, or diastolic blood pressure ≤ 60 mmHg, age ≥ 65 years) and the pneumonia severity index (PSI), and examine its usefulness for predicting mortality and ICU admission in patients with CAP of high severity and mortality that requires hospitalization.

METHODS: We performed a secondary analysis of data from a prospective observational study of adult patients who were admitted to our hospital between October 2010 and June 2016. We compared the prognostic performance of qSOFA, CURB-65, and PSI for predicting in-hospital mortality and ICU admission using the C statistics.

RESULTS: The median age of the 1045 enrolled patients was 77 (68-83) years, and 71.4% were males. The in-hospital mortality and ICU admission rates of the entire cohort were 6.1 and 7.9%, respectively. All scores were significantly higher in non-survivors and ICU admission patients than in survivors and non-ICU admission patients (p < 0.001). The C statistics of qSOFA for predicting in-hospital mortality was 0.69 (95% CI 0.63-0.75), and no significant differences were observed between CURB-65 (C statistics, 0.75; 95% CI 0.69-0.81) and PSI (C statistics, 0.74; 95% CI 0.69-0.80). The C statistics of qSOFA for predicting ICU admission was 0.76 (95% CI 0.71-0.80), and no significant differences were noted between CURB-65 (C statistics, 0.73; 95% CI 0.67-0.79) and PSI (C statistics, 0.72; 95% CI 0.66-0.78).

CONCLUSIONS: Regarding hospitalized CAP, the prognostic performance of qSOFA for in-hospital mortality and ICU admission was not significantly different from those of CURB-65 and PSI. qSOFA only requires a few items and vital signs, and, thus, may be particularly useful for emergency department or non-respiratory specialists.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Tokioka F, Okamoto H, Yamazaki A, et al. The prognostic performance of qSOFA for community-acquired pneumonia. J Intensive Care. 2018. PMID: 30116532. doi:10.1186/s40560-018-0307-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。